Single-Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in

Hui Li1, Changjiang Sun2, Minjie Yang3

  • 1Department of Endocrinology, Shaanxi Provincial People's Hospital, Xi'an City, Shaanxi Province, China.

Abstract

Insights

This study reveals the cellular complexity of osteosarcoma using single-cell RNA sequencing, identifying key genes like POSTN that may drive tumor progression and offer new therapeutic targets for this bone cancer.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Osteosarcoma is a prevalent pediatric bone cancer with poor prognosis for metastatic disease.
  • Understanding the tumor microenvironment's cellular complexity is crucial for targeted therapies.

Purpose of the Study:

  • To perform single-cell RNA sequencing on osteosarcoma to identify cellular heterogeneity.
  • To discover novel candidate genes and pathways involved in osteosarcoma progression.

Main Methods:

  • Single-cell RNA sequencing and bioinformatic analysis (Seurat, PCA, UMAP, Louvain clustering).
  • Differential gene expression analysis and functional enrichment (Gene Ontology, KEGG pathways).
  • Validation of candidate genes (F11, ACRP2, LEPR, POSTN) using qRT-PCR and ELISA.

Main Results:

  • Seven distinct cell clusters were identified, including macrophages, osteoblasts, fibroblasts, proliferating cells, osteoclasts, monocytes, and T cells.
  • Key pathways identified include PI3K-Akt signaling and extracellular matrix organization.
  • POSTN, LEPR, and ACRP2 were significantly upregulated, while F11 was downregulated at both mRNA and protein levels.

Conclusions:

  • Single-cell transcriptomics provides an atlas of osteosarcoma cellular heterogeneity.
  • F11, ACRP2, LEPR, and POSTN are potential biomarkers for osteosarcoma.
  • POSTN shows significant upregulation and may play a role in matrix remodeling, warranting further investigation as a therapeutic target.